
Découvrez Elsa BUREL – Alternante Production Anesthésique
Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a
Specialized in the manufacture of sterile products: from production of active ingredients to the manufacture of finished pharmaceutical products.
Recognised as a pharmaceutical site of excellence, a global reference for sterile products for over 50 years, we manufacture for international distribution:
FRAXIPARINE ™ / FRAXODI ™: Low molecular weight heparin indicated for venous thrombo-embolic events
ARIXTRA ™: The only injectable synthetic factor Xa inhibitor indicated both for venous thromboembolic disease and also the treatment of acute coronary syndrome
MONO EMBOLEX™: Low molecular weight heparin indicated for venous thromboembolic events
In a constantly changing regulatory environment and as a healthcare company, all our employees work with transparency and integrity so that our patients can trust Aspen.
We have mastered all the criteria that guarantee the absence of risks for the patient. Every day, in each of our actions, we think of him, he counts on us.
With a 170-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have more than 9 300 employees at 65 established offices in over 50 countries and we improve the health of patients in more than 115 countries through our high quality, affordable medicines.
Aspen focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through our key business segments. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Injectable products, Prescription and OTC medicines. Our manufacturing capabilities cover a wide variety of product types including steriles, oral solid dose, liquids, semi-solids, biologicals and active pharmaceutical ingredients.
We operate 23 manufacturing facilities across 16 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines.

Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a

Décarbonation : Aspen réunit les acteurs locaux

Développement durable : la parole à nos équipes